RACGAP1 and hepatocellular carcinoma: In addition, increasing evidence reveals that RACGAP1 contributes to tumorigenesis and malignant progression of several malignancies, such as hepatocellular carcinoma 6, bladder cancer 7, gastric cancer 8, and breast cancer 9.